OpenAI announced Thursday that it has entered into an agreement to acquire Astral, the company behind popular open source Python development tools such as uv, Ruff, and ty, and integrate the company ...

During an investigation into exposed OpenWebUI servers, the Cybernews research team identified a malicious campaign targeting vulnerable OpenWebUI servers with cryptocurrency miners and Info Stealers.

A metabolic enzyme studied for over seven decades has a hidden second function—it can unwind RNA and promote cell cycle progression, an additional function beyond its role in energy production, ...

From a $5m admission ticket to a national scandal, Michael Palin and Terry Gilliam reveal how the Pythons survived the chaotic making of a masterpiece.

From Hugh Grant to Scarlett Johansson, these actors won a BAFTA for a lead role despite not even receiving an Oscar nomination.

If you work with strings in your Python scripts and you're writing obscure logic to process them, then you need to look into regex in Python. It lets you describe patterns instead of writing ...

Have you ever tried to send a huge document by email only to get the annoying "file too large" error? Or maybe you only needed to translimit one chapter from a 200-page report, but you sent the whole ...

Merck MRK-1.27%decrease; red down pointing triangle is shaking up the leadership of its main pharmaceutical unit as the U.S. drugmaker braces for sales pressure later this decade. The Rahway, ...

Merck said on Monday it would split its business into two, creating ⁠a distinct division for its cancer franchise led by blockbuster drug Keytruda while grouping its non-oncology treatments separately ...

Merck to split business into oncology and non-oncology units Split does not involve its animal health division Key patents on Keytruda will begin to expire in 2028 Feb 23 (Reuters) - Merck (MRK.N), ...

Merck & Co. is reorganizing its main pharmaceutical business in a bid to better prepare for a patent “cliff” threatening a large chunk of its future revenue. The big drugmaker on Monday said it’s ...